Medtronic EPS (Basic) decreased by 16.8% to $0.89 in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 11.9%, from $1.01 to $0.89. Over 3 years (FY 2022 to FY 2025), EPS (Basic) shows relatively stable performance with a -1.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates improved profitability or a reduction in share count, while a decrease suggests declining earnings or equity dilution.
Basic earnings per share represents the portion of a company's profit allocated to each outstanding share of common stoc...
Investors compare this across large-cap technology peers to assess the efficiency of earnings generation relative to the equity base.
is_eps_basic| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.57 | $0.97 | $1.10 | $1.11 | $0.70 | $0.32 | $0.92 | $0.89 | $0.59 | $0.68 | $0.99 | $0.51 | $0.81 | $0.99 | $1.01 | $0.82 | $0.81 | $1.07 | $0.89 |
| QoQ Change | — | +70.2% | +13.4% | +0.9% | -36.9% | -54.3% | +187.5% | -3.3% | -33.7% | +15.3% | +45.6% | -48.5% | +58.8% | +22.2% | +2.0% | -18.8% | -1.2% | +32.1% | -16.8% |
| YoY Change | — | — | — | — | +22.8% | -67.0% | -16.4% | -19.8% | -15.7% | +112.5% | +7.6% | -42.7% | +37.3% | +45.6% | +2.0% | +60.8% | +0.0% | +8.1% | -11.9% |